National survey launched to assess inpatient diabetes care across England
A national survey has been launched to assess the quality and safety of inpatient diabetes care and understand the impact of diabetes care on patients across NHS trusts in England.
The Getting It Right First Time (GIRFT) Diabetes Programme is undertaking the National GIRFT Inpatient Diabetes Bedside Survey, covering both acute and community inpatient settings.
The survey follows the GIRFT survey of inpatient diabetes service provision carried out in 2024, which highlighted a substantial increase in the number of hospital inpatients with diabetes since the 2019 National Diabetes Inpatient Audit (NaDIA), without a corresponding increase in workforce capacity.
UK-wide survey aims to improve guidance on diabetic ketoacidosis in pregnancy
Members of the Association of British Clinical Diabetologists (ABCD) are being asked to take part in a UK-wide evaluation of current guidance for the diagnosis and management of diabetic ketoacidosis in pregnancy (pDKA).
Diabetic ketoacidosis in pregnancy is an uncommon but life-threatening emergency for both mother and fetus, with many women presenting with euglycaemic DKA, where blood glucose levels may not be as high as typically expected in DKA.
Recent studies have highlighted the need for consistent management to support timely and coordinated multidisciplinary care, prompting calls for standardised national UK guidance on the management of pDKA.
Registration opens for WAND annual conference 2026
We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference. The sponsoring companies are AgaMatrix Europe Limited, A. Menarini Farmaceutica Internazionale SRL, Ascensia Diabetes Care UK Ltd, Dexcom, Glooko, Insulet corporation, Lilly, A medicines Company, mylife Diabetes Care, Roche and Tandem Diabetes UK Limited.
Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers.
Registration is now open for the Welsh Academy for Nursing in Diabetes (WAND) annual conference, a free educational event bringing together diabetes specialist nurses from across Wales for a day of learning, discussion and networking.
Taking place on Friday 2 October 2026 at the Leonardo Hotel in Cardiff, the annual event provides an opportunity for nurses working in diabetes to come together, share knowledge and explore the latest developments in diabetes care.
NEUROdiab seeks sixth member for Youth Committee
NEUROdiab is inviting applications from early career researchers to become the sixth and final member of its Youth Committee, with applications closing on 22 September 2026. Click here.
Professor Ketan Dhatariya reappointed as Chair of ABCD
Professor Ketan Dhatariya is “humbled” to be reappointed as ABCD Chair, following the completion of his first term of office, 3 years ago. Click here.
Empowering behaviour change in people with cardiometabolic disease
The role of lifestyle medicine and how it can work effectively at neighbourhood level is the subject of a joint speaker session at the inaugural CVRM Professional Care next month.
Delegates will hear how lifestyle medicine can be integrated into routine clinical practice to support people living with, and at risk of, cardiometabolic disease.
Speakers Dr Camille Hirons, GP and Vice President of the British Society of Lifestyle Medicine, and Nana Ocran, Lead Diabetes Lifestyle Medicine Coach at North Lewisham PCN, will outline how multidisciplinary teams can provide – alongside clinical care – personalised support and empower behaviour change around the six pillars of lifestyle medicine.
What happens after the sensor goes on?
As continuous glucose monitoring becomes an established part of diabetes care, attention is shifting from access to what happens next. Donna Sutton, Lead Community Diabetes Specialist Nurse at Newcastle upon Tyne Hospitals NHS Foundation Trust and Clinical Lead at Spirit Health, discusses why education and ongoing support are essential to helping people interpret their glucose data, act on it with confidence and ultimately get more from the technology.
What happens after the sensor goes on?
By Donna Sutton, Lead Community Diabetes Specialist Nurse at Newcastle upon Tyne Hospitals NHS Foundation Trust and Clinical Lead at Spirit Health.
When Continuous Glucose Monitoring (CGM) first became widely available, the conversation was almost entirely about the technology. Accuracy, warm-up times, sensor life and connectivity.
Those conversations are important. They help build confidence in CGM and give us clinicians the evidence we need to adopt something new.
CLEAR study seeks UK participants to investigate restoring hypo awareness
A major international trial is recruiting people with type 1 diabetes to investigate whether diabetes technology, psychoeducation or a combination of the two is most effective at restoring impaired awareness of hypoglycaemia.
The CLEAR study is a multinational randomised controlled trial involving eight sites across the UK, US and Australia, with a recruitment target of 324 participants. UK recruitment is taking place in Leicester and Sheffield, where researchers are keen to reach more people who may be eligible for the study.
Abbott’s Libre established as the “most connected CGM in the world”
Abbott announced the integration of its FreeStyle Libre 3 Plus sensor with Insulet’s Omnipod® 5 Automated Insulin Delivery (AID) System in the UK, further expanding connected care options for people living with Type 1 diabetes who use a Libre sensor.
MiniMed’s first app-controlled insulin pump receives CE Mark in Europe
MiniMed’s first app-controlled insulin pump has received CE Mark in Europe, bringing the company’s smallest pump design to people living with insulin-treated diabetes across the continent.
Kidney Research UK and Royal College of Nursing come together to strengthen kidney care
Kidney Research UK and the Royal College of Nursing (RCN) have joined forces to develop a new resource designed to help nurses identify and manage chronic kidney disease (CKD), including among people living with diabetes.
The organisations have collaborated on a practical roles and responsibilities guide which sets out the actions nursing staff can take at different levels of practice when caring for people with, or at risk of, kidney disease.
The Big Interview: Pete Revell on improving CKD awareness and support
Watch now: Diabetes Times Editor Oliver Jelley speaks with Pete Revell, Head of Marketing and Fundraising at the National Kidney Federation (NKF), for the latest Big Interview.
Pete discusses CKD Connect, a new national initiative designed to improve awareness, education and support for people living with chronic kidney disease (CKD), while giving healthcare professionals trusted resources they can signpost patients to.
SGLT2 inhibitor ketoacidosis risk persists throughout treatment, study finds
People with type 2 diabetes taking SGLT2 inhibitors can remain at risk of ketoacidosis throughout treatment, with certain patient characteristics associated with substantially higher risk, a major Scandinavian study has found. Click here.
Strict blood sugar control may reduce quality of life for people with diabetes
Research to be presented at EASD in Milan, Italy (Sept 28–Oct 2) shows that, in people living with type 1 or type 2 diabetes, days with greater fluctuations in glucose levels – while remaining within safe limits – are followed by days with better quality of life than those with stricter glucose control. Click here.
Researcher named among the NIHR standout national research leaders
Dr Sharon Caunt, Sheffield Teaching Hospitals NHS Foundation Trust Research Coordinator at the Academic Unit of Diabetes and Endocrinology is one of 20 nationally to be honoured with a NIHR20 Research Delivery Leaders prize in recognition of her exceptional contribution to diabetes and endocrinology research.
The Kar Report
What needs to change in diabetes care — and what’s getting in the way?
Coming soon to the Diabetes Times, The Kar Report by Dr Partha Kar will examine some of the persistent issues affecting diabetes care across the UK.
From postcode variation in access to diabetes technology, to leadership challenges and the blame-heavy language that can still be heard in clinical settings, the report will look at where inequalities and outdated approaches remain.
Direct, considered and focused on the realities of diabetes care.
The Kar Report — coming soon to the Diabetes Times.
Bringing you the latest jobs from around the country within the field of diabetes.
Diabetes Specialist Nurse - Epsom and St Helier University Hospitals NHS Trust
Diabetes Specialist Podiatrist - Frimley Health NHS Foundation Trust
Diabetes Specialist Midwife - Sheffield Teaching Hospitals NHS Foundation Trust
Specialist Dietitian (Paediatric Diabetes) - Bedfordshire Hospitals NHS Foundation Trust
Join the expanding diabetes community on X and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
